Exact Sciences’ Post

Tomorrow is a Big Day: Bipartisan Legislation to Advance Innovative Cancer Early Detection Tests The American Cancer Society Cancer Action Network, along with 51 other national advocacy organizations, is calling on Congress to pass the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act. This crucial legislation, which will be marked up tomorrow, ensures that Medicare enrollees have access to innovative MCED tests once approved by the FDA and proven clinically beneficial. Highlights of this legislation: • Support from 270 House Representatives: Including over 80% of the Ways and Means Committee and more than 70% of the Energy and Commerce Committee members. • Endorsement by 520+ organizations nationwide: Reflecting broad, bipartisan support across the country. The passage of this act has the potential to significantly impact the lives of millions of Medicare enrollees and their families by providing earlier and more accurate cancer detection. Read the full letter and see the list of supporting organizations here. American Cancer Society Cancer Action Network (ACS CAN) American Cancer Society #CancerDetection #HealthcareInnovation #Medicare #BipartisanSupport #CancerCare

Cancer touches every one of us, and there is a heavily reliance on #Medicare, as Rich MacKinnon of the Professional Fire Fighters of Massachusetts (PFFM)’s writes in this important piece. Today, #patients have available screening for just five of the hundreds of types of #cancer. Even as the spouse of a first responder who knows about LOD risks, it is still jarring to read that two out of three firefighters who die in the line of duty die of cancer. New multicancer early-detection technology, however, is changing the screening game to detect cancer earlier, and S.2085 or "the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act" would create a meaningful pathway for Medicare coverage of these new tools. That's why MassBio continues to endorse this legislation that has widespread, bipartisan support. https://lnkd.in/eG4UEqXX

Yesterday, the American Lung Association released our 6th Annual “State of Lung Cancer” Report. The 2023 “State of Lung Cancer” report highlights how the toll of #lungcancer varies by state and examines key indicators throughout the U.S. including: new cases, survival, early diagnosis, surgical treatment, lack of treatment and screening rates. This year’s report finds that #lung #cancer survival rates are improving for everyone, including people of color. In fact, the five-year lung cancer survival rate for people of color has increased by 17% in the last two years, helping close the health disparity gap. The “State of Lung Cancer” report reveals that nationally from 2015 to 2019, the lung cancer five-year survival rate increased 22% up to 26.6%. #Pennsylvania friends, learn more here:

Yesterday, the American Lung Association released our 6th Annual “State of Lung Cancer” Report. The 2023 “State of Lung Cancer” report highlights how the toll of #lungcancer varies by state and examines key indicators throughout the U.S. including: new cases, survival, early diagnosis, surgical treatment, lack of treatment and screening rates. This year’s report finds that #lung #cancer survival rates are improving for everyone, including people of color. In fact, the five-year lung cancer survival rate for people of color has increased by 17% in the last two years, helping close the health disparity gap. The “State of Lung Cancer” report reveals that nationally from 2015 to 2019, the lung cancer five-year survival rate increased 22% up to 26.6%. Check out Pennsylvania: https://lnkd.in/e-7yT8f

A delayed cancer diagnosis and a series of hold-ups in referrals, appointments and communication with the patient left our client waiting months for treatment and her colorectal polyps developed into bowel cancer. This was yet another claim for a delayed diagnosis of cancer settled against the Northern Care Alliance NHS Foundation Trust. “Potentially, it’s a backlog from the pandemic, but sadly, we are seeing more clients who have been diagnosed late with cancer. Cases like this would have been treatable had they been spotted earlier, or the patient’s treatment would not have been as invasive,” said Solicitor and Head of Medical Negligence Jacqueline White. 𝗟𝗮𝘁𝗲 𝗕𝗼𝘄𝗲𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 In this case, our client’s polyps were such that when they were initially assessed, it should have been clear that they carried an increased risk of bowel cancer. Guidelines state that they should have then been removed completely, but in a breach in duty of care by the defendant, they went untreated for some time. From her initial appointment in August, presenting with altered bowel habits, it was ten months later when she was finally treated, and what were once benign polyps had become a malignant rectal adenocarcinoma. Read more here : ➡️ https://ow.ly/LIYi50PQCyh #bowelcancer #medicalnegligence #royaloldhamhospital #adenocarcinoma #colorectalpolyps #benignpolyps

POSTCOVID-19 WAR era, Radical suggestions and (re)call to all hematooncologist and especially to oncologists about Medicare and Medicaid of cancer patients from 2024. One is observing dramatic survival chances of cancer patients less than 10 years, however. On the other hand, a significant increase in mortality and morbidity rates of certain cancer patients, who were supposed to survive at least more than one year (even up to 25 years). Our team suggestion would be rapid changes in education and immediate replacement and removal of current (Main)Policy makers/ Managers, who are leading cancer R&D toward certain Economic-based Sciences. One can imagine that the know-how is still missing after 200 years studies but if now worldwide, no changes take place, we will be the next cancer patients without appropriate Medicare and Medicaid, in the near future.

Yesterday, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act was included in its first-ever legislative hearing! Congressman Raul Ruiz (D-Calif.), one of the bill’s co-sponsors, shared the following in his remarks: “Timing is of the essence as a physician. I've witnessed first-hand the positive impact that early detection of cancer can have on patient outcomes and the fatal consequences that can arise when a diagnosis comes too late.” When it comes to cancer, we need time on our side. Tuesday’s hearing was a major milestone for this important piece of legislation that, once passed, will ensure older Americans with Medicare have access to these potentially lifesaving tests. We are proud to stand alongside more than 500 organizations who endorse this legislation as a crucial step toward improving access to care for seniors. ➡️ Learn more about multi-cancer early detection: https://bit.ly/3Efv9sR #mced #multicancerearlydetection #energyandcommerce #congress #innovation #cancerscreening #cancer #cancerprevention #earlydetection

"What you're going to see in the future is risk-bearing primary care groups, taking on more Medicare Advantage lives, more Medicare lives, and steering those patients away from the hospital. Creating partnerships with those risk-bearing primary care groups moving forward is the future," said David Eagleton, Oncology Care Partners, at this year's Clinical Pathways Congress + Cancer Care Business Exchange. Eagleton shared his thoughts on the growth of Medicare Advantage and its impact on community oncology practices in providing value-based care. Watch the full interview here 👉 https://lnkd.in/eGE-8YQA #JournalOfClinicalPathways #ClinicalPathways #Cancer #CancerCareCost #CostOfCare #Medicare #MedicareAdvantage #ValueBasedCare

It’s positive to see the NHS making progress in the face of significant challenges. Encouragingly, more patients are being treated than ever, and the backlog of cancer patients in England has been reduced to pre-pandemic levels. However, despite this progress, today’s data shows how far there still is to go. While it's promising that more people are finding out if they have cancer or not faster, too many patients are still waiting too long to begin cancer treatment, which was already a problem before the pandemic. The last time all cancer wait targets were met in England was as far back as 2015. As we near a general election, tackling these problems must be a top priority for all political parties. The NHS is doing its best with what it has, but our health service urgently needs more staff and equipment, alongside reform to cancer services. By 2040 there will be half a million new cancer cases diagnosed every year. Only with long-term planning and increased investment will we see improved outcomes and improved performance that cancer patients rightly demand. https://lnkd.in/dkPp78R3

The American Lung Association's "State of Lung Cancer" report explores how lung cancer varies by state. It does this by analyzing key lung cancer indicators including incidence, survival, stage at diagnosis, surgical treatment, lack of treatment and screening rates. Learn more about how lung cancer is affecting your state and contact lawmakers urging them to save lives by protecting and expanding access to quality and affordable healthcare. https://ow.ly/Ylgw50QmUQI